12-57796359-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005726.6(TSFM):c.754G>A(p.Val252Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00243 in 1,604,190 control chromosomes in the GnomAD database, including 77 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_005726.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSFM | NM_005726.6 | c.754G>A | p.Val252Ile | missense_variant | 6/6 | ENST00000652027.2 | NP_005717.3 | |
TSFM | NM_001172696.2 | c.817G>A | p.Val273Ile | missense_variant | 7/7 | NP_001166167.1 | ||
TSFM | NM_001172695.2 | c.*162G>A | 3_prime_UTR_variant | 5/5 | NP_001166166.1 | |||
TSFM | NM_001172697.2 | c.571+3286G>A | intron_variant | NP_001166168.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSFM | ENST00000652027.2 | c.754G>A | p.Val252Ile | missense_variant | 6/6 | NM_005726.6 | ENSP00000499171 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0126 AC: 1924AN: 152216Hom.: 39 Cov.: 32
GnomAD3 exomes AF: 0.00328 AC: 758AN: 231108Hom.: 15 AF XY: 0.00241 AC XY: 300AN XY: 124640
GnomAD4 exome AF: 0.00136 AC: 1978AN: 1451856Hom.: 38 Cov.: 31 AF XY: 0.00117 AC XY: 845AN XY: 721300
GnomAD4 genome AF: 0.0126 AC: 1924AN: 152334Hom.: 39 Cov.: 32 AF XY: 0.0123 AC XY: 919AN XY: 74484
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 21, 2015 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
TSFM-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 27, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at